Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (ICAC-20)

Trial Profile

Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (ICAC-20)

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Jun 2017

At a glance

  • Drugs Fluticasone propionate (Primary) ; Omalizumab (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms PROSE
  • Most Recent Events

    • 13 Jun 2017 Results published in the American Journal of Respiratory and Critical Care Medicine
    • 24 May 2017 Results of association of microbiota existence and disease features presented at the 113th International Conference of the American Thoracic Society
    • 23 Feb 2017 Results (n=348) of post hoc analysis validating saEPI, published in the Journal of Allergy and Clinical Immunology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top